RAFAELLA WALLACE: Open Payments
NPI 1821469107 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$141 in 7 payments from 6 companies in 2025. Trend: 2023 $456 · 2024 $730 · 2025 $141
Food & beverage: $141
| Company | Payments | Amount |
|---|---|---|
| SOBI, INC | 2 | $49 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| BeiGene USA, Inc. | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: Doptelet, KEYTRUDA, LIBTAYO, BRUKINSA, JEMPERLI, ICLUSIG.
Industry payments across TX — which companies pay providers there.
